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Introduction {#sec001}
============

*Gastrodia elata* (*G*. *elata*) is frequently used in traditional Chinese medicine (TCMs). TCMs made from root extractsare mainly used to treat vertigo, blackouts, headaches, dizziness, rheumatism, hemiplegia, and epileptic convulsions \[[@pone.0150647.ref001]--[@pone.0150647.ref003]\]. Many bioactive compounds have been isolated from *G*. *elata*, which include phenolics (4-hydroxybenzaldehyde, 4-hydroxybenzyl alcohol, gastrodin, and parishin), citric acid, and amino acids \[[@pone.0150647.ref004],[@pone.0150647.ref005]\]. In recent years, the use of *G*. *elata* has increased rapidly as commercial preparations have become more readily available \[[@pone.0150647.ref006]\]. The compounds found in *G*. *elata* have been reported to possess anti-epileptic \[[@pone.0150647.ref007]\], anti-obesity \[[@pone.0150647.ref008]\], anti-convulsive \[[@pone.0150647.ref009]\], anti-oxidative \[[@pone.0150647.ref010]\] and memory enhancing properties \[[@pone.0150647.ref011]\].

The pharmacological properties of *G*. *elata* extracts are largely attributable to the presence of accumulated secondary metabolites. Although metabolite studies have, so far, focused mainly on the medicinal properties of *G*. *elata* products and extracts, a metabolite survey could also provide information about the genetic and biochemical control of the metabolism during the plant's development. Additionally, *G*. *elata* may provide an interesting model for studying other biological processes and metabolic regulation \[[@pone.0150647.ref012]--[@pone.0150647.ref014]\].

The most abundant compound in *G*. *elata*, and also the main active ingredient, is parishin, an ester formed by the condensation of three gastrodin subunits. However, the *Chinese Pharmacopoeia* \[[@pone.0150647.ref015]\] designates parishin as the only characteristic ingredient of *G*. *elata*. Recently, though, many more compounds have been identified in *G*. *elata* by using mass spectrometry (MS). In one study \[[@pone.0150647.ref016]\], some parishin compounds that would be expected to occur in *G*. *elata* were not identified, and only m/z values of those identified in MS process were presented. It was challenging to make progress in the analysis of *G*. *elata* compounds. Furthermore, little information is available about the composition and content of metabolites in different cultivars of *G*. *elata*, as well as the relationship between the *G*. *elata* cultivars and their area of origin. A survey of these cultivars and their areas of orgin would therefore be valuable.

In addition to the above issues, separation efficiency and resolution of target peaks of compounds extracted from plant are common bottlenecks in the qualitative and quantitative analysis of metabolism \[[@pone.0150647.ref017]\]. If suitable separation protocols can\'t be established, the use of inappropriate protocols may influence the results of an analysis. The purpose of the present study was to develop a complete systematic method for the qualitative and quantitative analysis of the major bioactive compounds extracted from roots of *G*. *elata* by using ultra performance liquid chromatography (UPLC) coupled with ESI-triple quadrupole ion MS and ESI-linear ion trap high-resolution MS. To the best of our knowledge, this is a report describing a simple and time-saving analytical method for the simultaneous determination of multiple metabolites in fresh root samples from *G*. *elata*.

Experimental {#sec002}
============

The study was carried out on private land and we confirmed that the owner of the land gave us the permission to conduct the study on this site.

Chemicals and standards {#sec003}
-----------------------

HPLC grade acetonitrile used for HPLC-MS analysis, including acetonitrile and formic acid, were of HPLC grade (CNW, Dusseldorf, Germany). Formic acid was HPLC-grade obtained from Sigma-Aldrich (St. Louis, MO, USA). Waters used in the experiment was de-ionized and further purified by a Milli-Q Plus water purification system (Millipore Ltd.). Other reagents and chemicals were of analytical grade purchased from Beijing Chemistry factory Corporation. Gastrodin, parishin E, parishin B, and parishin were purchased from the National Institute for the control of Biological and Pharmaceutical Drugs (Beijing, China).

Plant materials {#sec004}
---------------

Rhizomes from eight *G*. *elata* cultivars were collected from three independent populations; each population contained 60 individual plants. The eight cultivars were of four species (green, red, black, and hybrid) obtained from four representative provinces ([Table 1](#pone.0150647.t001){ref-type="table"}). Three replicates of eight cultivars were manually collected in late December (12/24, 2013) from three individual plants of each cultivars. The collected rhizomes specimens were identified as *Gastrodia elata* Bl by a taxonomist (Professor Ming Cheng) at Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

10.1371/journal.pone.0150647.t001

###### *G*. *elata* cultivars used in this study.

![](pone.0150647.t001){#pone.0150647.t001g}

  Cultivars   Genotype groups   Place of collection (City-Province)   Coordinates (Latitude-Longitude)   Time of collection
  ----------- ----------------- ------------------------------------- ---------------------------------- --------------------
  1           Red\#             Bijie-Guizhou                         27°18\'-105°18\'                   December 21, 2013
  2           Green\#           Bijie-Guizhou                         27°18\'-105°18\'                   December 21, 2013
  3           Black\#           Bijie-Guizhou                         27°18\'-105°18\'                   December 21, 2013
  4           Red\#             Yaan-Sichuan                          29°59\'-103°01\'                   December 22, 2013
  5           Green\#           Yaan-Sichuan                          29°59\'-103°01\'                   December 22, 2013
  6           Hybrid\#          Yaan-Sichuan                          29°59\'-103°01\'                   December 22, 2013
  7           Red\#             Hanzhong-Shanxi                       33°04\'-107°01\'                   December 24, 2013
  8           Hybrid\#          Zhaotong-Yunnan                       27°20\'-103°43\'                   December 25, 2013

Sample preparation {#sec005}
------------------

For each freeze-dried sample of *G*. *elata* root, a portion (0.5 g, 100 mesh) was accurately weighed into a 50 mL flask and extracted with 20 mL 50% aqueous methanol (methanol: water 50:50, v/v) in an ultrasonic bath for 30 min at room temperature. Each extract combination was performed in triplicate. The extract was centrifuged for 5 min at 15, 000 g, the supernatant was collected and all the samples were re-extracted as above twice more. The combined supernatant was then filtered through a 0.22-μm Millipore filter (Alltech Scientific Corporation, Beijing, China) before injection for LC/MS analysis.

UPLC method {#sec006}
-----------

Chromatographic separation was performed using a UPLC system (DaianU3000, Dionex Corparation, CA, USA). The equipment comprised an UPLC pump, a photodiode array (PDA) detector, and an auto-sampler set at 30°C. Phenolic detection in diode array detector was carried out at 270 nm, and spectrum scans were made from 200 to 400 nm. Separations were carried out using an Accucore C~18~ column (2.1 mm × 100 mm, 2.6 μm particle size, Thermo Fisher Scientific, Bellefonte, PA, USA). The mobile phase consisted of water containing 0.1% formic acid (A) and acetonitrile (B). Linear gradient elution was performed at a flow rate of 0.2 mL/min. The solvent gradient was changed according to the following program: 0--8 min, 2% B; 8--12 min, 2--8% B; 12--25 min, 8--12% B; and 25--47 min, 12--25% B. The injection volume was 1 μL and chromatograms were acquired at 270 nm.

Q-Trap MS {#sec007}
---------

MS analysis was performed using an LTQ Orbitrap mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA), fitted with an electrospray ionization (ESI) source operated in both negative and positive modes. The m/z range was 100--1200, with resolution set at 30000 using the normal scan rate. Data-dependent MS/MS events were always performed on the most intense ions detected in the full scan MS. The normalized collision energy was 30% for all compounds. Nitrogen was used as the sheath gas and helium as the collision gas. The key optimized ESI parameters were as follows: source voltage, 3.0 kV; sheath gas (nitrogen), 50 L/min; auxiliary gas flow, 10 L/min; capillary voltage, -35.0 V; capillary temperature, 350°C, and tube lens, -110.0 V. The ion injection time used was 50.0 ms. MS scan functions and UPLC solvent gradients were controlled by an X-calibur data system (Thermo Fisher, Scan Jose, CA, USA).

ESI-QQQ-MS {#sec008}
----------

Triple quadrupole (QQQ) scans were acquired using an Agilent 1290 UPLC-photodiode array 6460 triple quadrupole mass spectrometry system (Agilent Technologies, Palo Alto, CA, USA). The ESI source operation parameters were as follows: HV voltage, 3.5 kV; capillary, 7 μA; nozzle voltage, 500 V; delta emv, 300 V; gas flow, 5 L/min; gas temp, 350°C; nebulizer, 45 psi; sheath gas temp, 350°C; and sheath gas flow, 11 L/min.

Method validation {#sec009}
-----------------

The method was validated by characteristic indexes including linearity, the limit of detection (LOD), the limit of quantification (LOQ) and precision (inter-day. intra-day precision).

Statistical analysis {#sec010}
--------------------

Quantitative data were analyzed with SPSS 16.0 for window. Principal component analyses (PCA) for identifying homogeneous groups of individual tissues based on measured phenolics, nucleosides and amino acids concentrations were performed in SPSS 16.0. Factors were identified using varimax rotation and the two most significant factors were extracted using the Kaiser-Meyer-Olkin criterio (KMO).

Results and Discussion {#sec011}
======================

Optimization of HPLC and MS conditions {#sec012}
--------------------------------------

In preliminary tests, three columns were evaluated for the separation of target compounds from the roots of *G*. *elata*. These were a SunFire C~18~ column (2.1 mm × 100 mm, 1.9 μm particle size, Waters Corporation, Milford, USA) ([Fig 1A-I](#pone.0150647.g001){ref-type="fig"}), an Acquity BEH C~18~ column (2.1 mm × 100 mm, 1.7 μm particle size, Waters Corporation, Milford, USA) ([Fig 1A-II](#pone.0150647.g001){ref-type="fig"}), and an Accucore C~18~ column (2.1 mm × 100 mm, 2.6 μm particle size, Thermo Scientific, USA) ([Fig 1A-III](#pone.0150647.g001){ref-type="fig"}). Using the same elution protocol, the Accucore C~18~ column ([Fig 1A-III](#pone.0150647.g001){ref-type="fig"}) gave slightly better resolution than the other two columns. Thus, it indicated that particle size may be an important factor affecting the resolution of compounds in *G*. *elata*. Based on earlier reports, two elution systems ([Fig 1B-I and 1B-II](#pone.0150647.g001){ref-type="fig"}) were then evaluated to optimize the peak shapes of metabolites separated from *G*. *elata*. Elution system B-I, in which acetic acid was added to the eluent, was based on research carried out by Wang \[[@pone.0150647.ref018]\], and allowed identification of 15 phenolics and 6 nucleoside derivatives in the roots of *G*. *elata*. Elution system B-II, in which 0.1% formic acid was added to the mobile phase, was based on research carried out by Ong et al. \[[@pone.0150647.ref019]\] and has been widely used to separate phenolics from the roots of *G*. *elata*. In the present study, we found that a higher concentration of formic acid (0.5%, v:v, B-III) improved peak separation efficiency ([Fig 1B-III](#pone.0150647.g001){ref-type="fig"}). Our research suggests that an Accucore C~18~ column and a mobile phase containing formic acid (0.5%) is suitable for the analysis of metabolites in *G*. *elata*. The optimized experiment condition was replicated for eight different cultivars analysis.

![Optimized HPLC chromatograms at 220 nm selected from three column system (AI---AIII) and three mobile protocols (BI-BIII). Thirty-one compounds (peaks 1--31) were separated by BIII and identified using UPLC- LTQ Orbitrap mass spectrometry.](pone.0150647.g001){#pone.0150647.g001}

Method validation {#sec013}
-----------------

### Calibration curves, limits of detection and quantification {#sec014}

Method validation was carried out using four external standards (gastrodin, parishin E, parishin B, and parishin). The calibration curves showed good linearity for all standards at 350 nm (*r*^2^ ≥ 0.9915). The standard solutions were detected by chromatography until the signal-to-noise (S/N) ratios were 3 and 10; the corresponding concentrations at these S/N ratios were defined as the LOD and LOQ, respectively. The lowest and highest LOD and LOQ were obtained for gastrodin (0.024 and 0.081 μg/mL) and parishin (0.359 and 1.196 μg/mL) ([Table 2](#pone.0150647.t002){ref-type="table"}).

10.1371/journal.pone.0150647.t002

###### The regression equation, LOD and LOQ of the four standards using the optimized method for calibration.
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  Compounds    Regression equation        *r*^2^   Linear range (μg/mL)   LOD (μg/mL)   LOQ (μg/mL)
  ------------ -------------------------- -------- ---------------------- ------------- -------------
  Gastrodin    *y* = 79899*x* - 1108.1    0.9999   8.89--44.48            0.024         0.081
  Parishin E   *y* = 19656*x* - 12538     0.9915   6.08--60.80            0.143         0.475
  Parishin B   *y* = 19656*x* - 12538     0.9981   34.50--138.00          0.104         0.345
  Parishin     *y* = 315580*x* - 7052.4   0.9999   40.66--203.30          0.359         1.196

*y*, peak area; *x*, compound concentration (μg/mL); LOD = limit of detection, S/N = 3; LOQ = limit of quantitation, S/N = 10

### Precision and accuracy of quantification {#sec015}

The precision of metabolite quantification was studied by examining the repeatability and intermediate precision for all compounds separated from *G*. *elata* roots. Six standard samples were evaluated on the same day to determine the intra-day precision. Three samples were also extracted and analyzed on three consecutive days to determine the inter-day precision. Sample solutions were prepared at three concentrations (low, middle, and high), with three replicates of each concentration in order to validate method precision. Relative standard deviations (RSDs) were calculated to assess repeatability and precision. The RSDs of the four compounds were less than 4.05% for inter-day precision at the three concentration and 4.00% for the intra-day precision ([Table 3](#pone.0150647.t003){ref-type="table"}). The low RSD values obtained for the four compounds confirmed the high repeatability and intermediate precision of the method developed here.

10.1371/journal.pone.0150647.t003

###### Intra- and inter-day precision of four standards by HPLC.
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  Compounds    Intra-day(n = 6)                                     Inter-day(n = 3)                   
  ------------ ---------------------------------------------------- ------------------ --------------- ------
  Gastrodin    9.48 ± 0.38 [^a^](#t003fn001){ref-type="table-fn"}   4.00               9.30 ± 0.23     2.46
               15.85 ± 0.59                                         3.72               15.15 ± 0.30    2.01
               27.09 ± 0.34                                         1.25               27.09 ± 0.45    1.34
  Parishin H   6.40 ± 0.21                                          3.35               6.29 ± 0.15     2.42
               8.99 ± 0.23                                          2.72               8.98 ± 0.15     1.48
               20.58 ± 0.66                                         3.18               20.02 ± 0.81    4.05
  Parishin B   35.82 ± 0.59                                         1.67               35.76 ± 0.67    1.87
               57.56 ± 0.74                                         1.28               59.52 ± 0.78    1.30
               118.34 ± 0.60                                        0.51               118.39 ± 0.66   0.21
  Parishin     50.88 ± 0.85                                         1.66               51.77 ± 0.41    0.80
               83.80 ± 0.61                                         0.72               84.08 ± 0.27    0.32
               167.23 ± 0.94                                        0.56               167.90 ± 0.81   0.48

^a^ Mean concentration ± SD.

^b^ RSD = (SD/mean) × 100

### Accuracy and recovery of quantification {#sec016}

The accuracy of the method was investigated by measuring the recovery. This was assessed by adding three concentrations (high, middle and low) of standard solutions to known amounts of sample solution which were then extracted and subjected to quantitative analysis as described above. Each standard was tested at each concentration in triplicate. The equation used to define the percentage recovery was (detected amount---original amount)/spiked amount x 100. Recoveries obtained in this study were in the range 88.02--105.38% ([Table 4](#pone.0150647.t004){ref-type="table"}), demonstrating that the analytical method developed in this study has high accuracy. The low RSDs of all standards (\< 1.54%) indicate good reproducibility.

10.1371/journal.pone.0150647.t004

###### Recovery of four standards in the extraction of GE (n = 3).
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  Compounds    Initial amount (mg)   Added amount (mg)   Total recovered amount[^a^](#t004fn001){ref-type="table-fn"} (mg)   Recovery[^b^](#t004fn002){ref-type="table-fn"} (%)   RSD[^c^](#t004fn003){ref-type="table-fn"} (%)
  ------------ --------------------- ------------------- ------------------------------------------------------------------- ---------------------------------------------------- -----------------------------------------------
  Gastrodin    1.09                  0.62                1.62 ± 0.01                                                         88.02                                                1.26
               1.09                  2.24                3.35 ± 0.03                                                         100.91                                               1.54
               1.09                  3.86                4.93 ± 0.01                                                         99.65                                                0.30
  Parishin E   1.22                  0.42                1.62 ± 0.02                                                         94.65                                                0.57
               1.22                  2.04                3.33 ± 0.03                                                         105.38                                               1.46
               1.22                  4.11                5.01 ± 0.03                                                         92.15                                                0.70
  Parishin B   1.14                  0.32                1.43 ± 0.00                                                         89.88                                                0.52
               1.14                  1.72                2.88 ± 0.01                                                         101.96                                               0.58
               1.14                  3.45                4.35 ± 0.00                                                         92.85                                                0.13
  Parishin     2.55                  2.87                5.34 ± 0.01                                                         97.66                                                0.34
               2.55                  8.23                10.78 ± 0.02                                                        100.43                                               0.00
               2.55                  13.86               16.21 ± 0.01                                                        98.49                                                0.07

^a^ Total recovered amount = mean content ± SD.

^b^ Recovery (%) = (detected amount---original amount)/spiked amount × 100.

^c^ RSD = (recovery SD/mean) × 100

Analysis of constituents in *G*. *elata* {#sec017}
----------------------------------------

The identification of 31 compounds was performed in both positive and negative modes. Chemical structures, mass spectra (in PI, NI and NI-MS/MS), retention times, UV-Vis spectra, and retention times on the C~18~ column are listed in [Table 5](#pone.0150647.t005){ref-type="table"}. The identified compounds could be classified into three groups, phenolics, nucleosides and amino acids, based on their chemical structures.

10.1371/journal.pone.0150647.t005

###### Characterization of constituents extracted from gastrodia by ESI- linear ion trap high-resolution MS.
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  No.   Rt (min)   NI^−^                       PI^+^                                                                                                                                                                                                                  λmax (nm)   Identification                                                                                                                                                                                                                                                    
  ----- ---------- --------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------- ----- --------------------------------------------------
  1     2.44       191.0198                    111.10\[M-H-2H~2~O-CO~2~\]^−^, 173.10\[M-H-H~2~O\]^−^                                                                                                                                                                  215.0160    197.10\[M+Na-H~2~O\]^+^                                                                                                                                                                                                                             ---     256   Citric Acid
  2     3.17       243.0123                    ---                                                                                                                                                                                                                    267.0196    113.10\[M+H-132\]^+^                                                                                                                                                                                                                                ---     262   Uridine
  3     3.51       180.1078                    ---                                                                                                                                                                                                                    182.1056    165.10\[M+H-NH~3~\]^+^, 136.10\[M+H-HCOOH\]^+^                                                                                                                                                                                                      0.987   220   Tyrosine
  4     3.74       ---                         ---                                                                                                                                                                                                                    132.1020    115.10\[M+H-NH~3~\]^+^, 86.10\[M+H-HCOOH\]^+^                                                                                                                                                                                                       0.721   217   Leucine
  5     4.82       266.1567                    134.12\[M-H-132\]^−^                                                                                                                                                                                                   268.1031    136.10\[M+H-132\]^+^                                                                                                                                                                                                                                1.344   259   Adenosine
  6     6.36       331.1044                    161.12\[Glu-H\]^−^, 123.12\[M-Glu-H\]^−^                                                                                                                                                                               309.0925    185.10\[Glu+Na\]^+^                                                                                                                                                                                                                                 0.537   220   Gastrodin
  7     8.12       ---                         ---                                                                                                                                                                                                                    127.1091    108.10\[M+H- H~2~O\]^−+^                                                                                                                                                                                                                            ---     285   5-hydroxymethyl fural
  8     11.37      123.1098                    105.12\[M-H- H~2~O\]^−^                                                                                                                                                                                                ---         ---                                                                                                                                                                                                                                                 0.503   220   P-hydroxybenzyl alcohol
  9     21.83      621.1660                    441.10\[M-H-162-H~2~O\]^−^, 459.10\[M-H-162\]^−^, 397.10\[M-H-162-H~2~O-CO~2~\]^−^, 369.10\[M-H-162-CO~2~\]^−^                                                                                                         645.1136    539.10\[M+Na-106\]^+^, 483.10\[M+Na-162\]^+^, 377.10\[M+Na-268\]^+^, 215.10\[M+Na-268-162\]^+^                                                                                                                                                      0.411   222   Mono-substituted parishin glucoside
  10    23.25      459.1145                    173.10\[M-H-268-H~2~O\]^−^, 129.10\[M-H-268-H~2~O-CO~2~\]^−^                                                                                                                                                           483.1123    377.11\[M+Na-106\]^+^, 321.11\[M+Na-162\]^+^, 215.11\[M+Na -268\]^+^, 185.11\[Glu+Na\]^+^                                                                                                                                                           0.493   221   parishin H
  11    25.15      459.1145                    173.10\[M-H-268-H~2~O\]^−^, 129.10\[M-H-268-H~2~O-CO~2~\]^−^                                                                                                                                                           483.1091    377.10\[M+Na-2CO~2~-H~2~O\]^+^, 321.10\[M+Na-162\]^+^, 215.10\[M+Na -268\]^+^, 185.10\[Glu+Na\]^+^                                                                                                                                                  0.679   221   parishin E
  12    25.72      412.1178                    306.10\[M-H-106\]^−^                                                                                                                                                                                                   414.1331    339.10\[M+H-75\]^+^, 308.10\[M+H-106\]^+^, 285.12\[M+H-147+H~2~O\]^+^, 179.12\[M+H-147+H~2~O-106\]^+^, 233.12\[M+H-106-75\]^+^                                                                                                                      2.094   224   S-(4-hydroxybenzyl) -glutathione
  13    27.94      489.1247                    427.10\[M-H-H~2~O-CO~2~\]^−^, 173.10\[M-H-268-H~2~O-30\]^−^                                                                                                                                                            513.1048    377.00\[M+Na-2Co~2~-H~2~O\]^+^, 215.10\[M+Na-268-30\]^+^                                                                                                                                                                                            0.436   223   Methoxy mono-substituted parishin
  14    30.82      518.1593                    412.10\[M-H-162-106\]^−^, 306.10\[M-H-162-106-106\]^−^                                                                                                                                                                 520.3333    377.10\[M+Na-2CO~2~-H~2~O-30\]^+^, 339.10\[M+H-75-106\]^+^, 308.10\[M+H-106-106\]^+^, 285.10\[M+H-147+H~2~O-106\]^+^, 233.10\[M+H-106-75-106\]^+^, 179.10\[M+H-147+H~2~O-106-106\]^+^                                                               0.458   224   P-hydroxybenzyl s-(4-hydroxybenzyl) -glutathione
  15    32.91      889.2617                    621.10\[M-H-268\]^−^, 603.10\[M-H-268-H~2~O\]^−^, 585.10\[M-H-268-2H~2~O\]^−^, 559.10\[M-H-268-H~2~O-CO~2~\]^−^, 531.10\[M-3H-268-2CO~2~\]^−^, 423.10\[M-H-268-2H~2~O-162\]^−^, 397.10\[M-H-268-H~2~O-CO~2~-162\]^−^   913.2527    807.11\[M+Na-106\]^+^, 645.11\[M+Na-268\]^+^, 483.11\[M+Na-268-162\]^+^                                                                                                                                                                             ---     224   Di-substituted parishin glucoside
  16    35.50      727.2083                    471.10\[M-H-268-H~2~O\]^−^, 453.10\[M-H-268-2H~2~O\]^−^, 423.10\[M-H-268-2H~2~O-30\]^−^, 397.10\[M-H-268-H~2~O-CO~2~\]^−^, 369.10\[M-3H-268-2CO~2~-30\]^−^                                                             751.2071    645.10\[M+Na-106\]^+^, 483.10\[M+Na-268\]^+^, 539.10\[M+Na-106-106\]^+^, 589.10\[M+Na-162\]^+^, 377.10\[M+Na-106-268\]^+^, 215.10\[M+Na-268-268\]^+^                                                                                                0.582   222   Di-substituted parishin
  17    36.13      727.2092                    459.10\[M-H-268\]^−^, 441.10\[M-H-268-H~2~O\]^−^, 423.10\[M-H-268-2H~2~O\]^−^, 397.10\[M-H-268-H~2~O-CO~2~\]^−^, 369.10\[M-3H-268-2CO~2~\]^−^                                                                          751.4514    645.10\[M+Na-106\]^+^, 483.10\[M+Na-268\]^+^, 539.10\[M+Na-106-106\]^+^, 589.10\[M+Na-162\]^+^, 377.10\[M+Na-106-268\]^+^, 215.10\[M+Na-268-268\]^+^                                                                                                0.692   222   parishin B
  18    36.22      889.2617                    621.10\[M-H-268\]^−^, 603.10\[M-H-268-H~2~O\]^−^, 585.10\[M-H-268-2H~2~O\]^−^, 559.10\[M-H-268-H~2~O-CO~2~\]^−^, 531.10\[M-3H-268-2CO~2~\]^−^, 423.10\[M-H-268-2H~2~O-162\]^−^, 397.10\[M-H-268-H~2~O-CO~2~-162\]^−^   913.1057    807.10\[M+Na-268+Glc\]^+^, 645.10\[M+Na-268\]^+^, 483.10\[M+Na-268-162\]^+^                                                                                                                                                                         ---     224   Di-substituted parishin glucoside isomer
  19    37.26      757.2189                    471.10\[M-H-268-H~2~O\]^−^, 453.10\[M-H-268-2H~2~O\]^−^, 423.11\[M-H-268-2H~2~O-30\]^−^, 397.10\[M-H-268-H~2~O-CO~2~\]^−^, 369.10\[M-3H-268-2CO~2~-30\]^−^                                                             781.4503    483.10\[M+Na-268-162-30\]^+^, 513.10\[M+Na-268\]^+^, 675.10\[M+Na-268+Glu\]^+^                                                                                                                                                                      5.178   225   Methoxy di-substituted parishin
  20    37.98      727PONE-D-15-37678R3.2070   459.10\[M-H-268\]^−^, 441.10\[M-H-268-H~2~O\]^−^, 423.10\[M-H-268-2H~2~O\]^−^, 397.10\[M-H-268-H~2~O-CO~2~\]^−^, 369.10\[M-3H-268-2CO~2~\]^−^                                                                          751.2071    645.10\[M+Na-106\]^+^, 483.10\[M+Na-268\]^+^, 539.10\[M+Na-106-106\]^+^, 589.10\[M+Na-162\]^+^, 377.10\[M+Na-106-268\]^+^, 215.10\[M+Na-268-268\]^+^                                                                                                3.049   222   parishin C
  21    39.11      757.2189                    471.10\[M-H-268-H~2~O\]^−^, 453.10\[M-H-268-2H~2~O\]^−^, 423.10\[M-H-268-2H~2~O-30\]^−^, 397.10\[M-H-268-H~2~O-CO~2~\]^−^, 369.10\[M-3H-268-2CO~2~-30\]^−^                                                             781.4555    483.10\[M+Na-268-162-30\]^+^, 513.10\[M+Na-268\]^+^, 675.10\[M+Na-268+Glu\]^+^                                                                                                                                                                      5.178   225   Methoxy di-substituted parishin isomer
  22    39.51      741.2240                    741.10\[M-H\]^−^, 473.10\[M-H-268\]^−^, 441.10\[M-H-268-H~2~O-14\]^−^                                                                                                                                                  765.2215    659.10\[M+Na-106\]^+^, 603.10\[M+Na-162\]^+^, 497.10\[M+Na-268-14\]^+^, 391.10\[M+Na-106-268\]^+^                                                                                                                                                   0.550   224   Methyl di-substituted parishin
  23    40.59      787.2303                    741.10\[M-H\]^−^, 473.10\[M-H-268\]^−^, 441.10\[M-H-268-H~2~O-14\]^−^                                                                                                                                                  765.1089    659.10\[M+Na-106\]^+^, 603.10\[M+Na-162\]^+^, 497.10\[M+Na-268-14\]^+^, 391.10\[M+Na-106-268\]^+^                                                                                                                                                   0.610   224   Methyl di-substituted parishin isomer
  24    42.02      1157.3546                   889.10\[M-H-268\]^−^, 727.10\[M-H-268-162\]^−^, 585.10\[M-H-2TMS\]^−^, 423.10\[M-H-2TMS-162\]^−^, 379.10\[M-H-2TMS-CO~2~-162\]^−^                                                                                      1181.1189   913.10\[M+Na-TMS+H~2~O\]^+^, 807.10\[M+Na-268-268+Glu\]^+^, 751.10\[M+Na-268-162\]^+^, 645.10\[M+Na-268-268+Glu-162\]^+^, 483.10\[M+Na-268-268-162\]^+^                                                                                             3.271   223   Parishin glucoside
  25    42.39      995.3034                    727.10\[M-H-268\]^−^, 441.10\[M-H-268-268-H~2~O\]^−^, 423.10\[M-H-268-268-2H~2~O\]^−^, 397.10\[M-H-268-268-H~2~O-CO~2~\]^−^, 379.10\[M-H-268-268-2H~2~O-CO~2~\]^−^                                                     1019.1771   913.10\[M+Na-106\]^+^, 857.10\[M+Na-162\]^+^, 807.10\[M+Na-106-106\]^+^, 751.10\[M+Na-268\]^+^, 645.10\[M+Na-268-268+Glu\]^+^, 589.10\[M+Na-162-268\]^+^, 539.10\[M+Na-106-106-268\]^+^, 483.10\[M+Na-268-268\]^+^, 377.10\[M+Na-106-268-268\]^+^   1.797   222   Parishin
  26    42.81      1025.3138                   757.10\[M-H-268\]^−^, 727.10\[M-H-268-30\]^−^                                                                                                                                                                          1049.3097   781.10\[M+Na-268\]^+^, 751.10\[M+Na-268--30\]^+^, 645.10\[M+Na-268-268+162--30\]^+^, 483.10\[M+Na-268-268-30\]^+^                                                                                                                                   0.760   224   Methyl parishin
  27    43.01      565.1553                    529.10\[M-H-2H~2~O\]^−^, 503.10\[M-H-CO~2~-H~2~O\]^−^, 459.10\[M-H-106\]^−^, 397.10\[M-H-106-H~2~O-CO~2~\]^−^, 173.10\[M-H-268-H~2~O-106\]^−^                                                                          589.1525    571.10\[M+Na-H~2~O\]^+^, 483.10\[M+Na-106\]^+^, 215.10\[M+Na-268-106\]^+^                                                                                                                                                                           0.091   224   P-hydroxybenzyl mono-substituted parishin
  28    43.89      565.1556                    529.10\[M-H-2H~2~O\]^−^, 503.10\[M-H-CO~2~-H~2~O\]^−^, 459.10\[M-H-106\]^−^, 397.10\[M-H-106-H~2~O-CO~2~\]^−^, 173.10\[M-H-268-H~2~O-106\]^−^                                                                          589.1523    571.10\[M+Na-H~2~O\]^+^, 483.10\[M+Na-106\]^+^, 215.10\[M+Na-268-106\]^+^                                                                                                                                                                           0.091   224   P-hydroxybenzyl mono-substituted parishin isomer
  29    44.34      833.2500                    727.10\[M-H-106\]^−^, 441.10\[M-H-268-H~2~O-106\]^−^, 397.10\[M-H-268-H~2~O-CO~2~-106\]^−^                                                                                                                             857.2483    751.10\[M+Na-106\]^+^, 645.10\[M+Na-268+162--106\]^+^, 589.10\[M+Na-268\]^+^, 483.10\[M+Na-268-106\]^+^, 377.10\[M+Na-268-106-106\]^+^                                                                                                              0.893   228   P-hydroxybenzyl di-substituted parishin
  30    45.91      833.2501                    727.10\[M-H-106\]^−^, 441.10\[M-H-268-H~2~O-106\]^−^, 423.10\[M-H-268-2H~2~O-106\]^−^, 397.10\[M-H-268-H~2~O-CO~2~-106\]^−^, 369.10\[M-3H-268-2CO~2~-106\]^−^, 263.10\[M-3H-268-2CO~2~-106-106\]^−^                    857.2461    751.10\[M+Na-106\]^+^, 645.10\[M+Na-268+162--106\]^+^, 589.10\[M+Na-268\]^+^, 483.10\[M+Na-268-106\]^+^, 377.10\[M+Na-268-106-106\]^+^                                                                                                              0.893   228   P-hydroxybenzyl di-substituted parishin isomer
  31    46.18      1101.3436                   995.10\[M-H-106\]^−^, 833.10\[M-H-268\]^−^, 727.10\[M-H-268-106\]^−^                                                                                                                                                   1125.3408   1019.10\[M+Na-106\]^+^, 857.10\[M+Na -268\]^+^, 589.10\[M+Na-268-268\]^+^, 483\[M+Na-268-268-106\]^+^                                                                                                                                               0.984   225   P-hydroxybenzyl parishin

Mass spectra of metabolites from *G*. *elata* in both positive and negative mode showed that the characteristic ions originated mainly from functional groups such as hydroxyl and carboxyl groups. By comparing UPLC retention times and UV and mss spectral data with those of reference standards, the target peaks were tentatively identified as described below.

### MS^n^ analysis of nucleosides in *G*. *elata* {#sec018}

In a previous reference, two nucleosides (peaks 2 and 5) that showed similar MS fragmentation patterns, including loss of a ribose moiety (132 Da), were identified in *G*. *elata* extracts. In positive ionization mode, nucleosides mainly showed molecular ions \[M+Na\]^+^; in negative ionization mode, abundant \[M-H\]^-^ or \[M+HCOO\]^-^ ions were observed. By comparison with literature data \[[@pone.0150647.ref018]\], peak 2 was tentatively identified as uridine. In positive mode, the MS/MS spectrum focused on the precursor ion \[M+Na\]^+^ (m/z 267.0196) showed a peak corresponding to loss of a ribose moiety (m/z 113, \[M+H-132\]^+^) ([Table 5](#pone.0150647.t005){ref-type="table"}). Peak 5 was tentatively identified as adenosine, based on an earlier report \[[@pone.0150647.ref020]\]. Its fragmentation pattern was similar to that of uridine, with a characteristic fragment at m/z 136 \[M+H-132\]^+^.

### Analysis of amino acids in *G*. *elata* {#sec019}

Although the UV absorption of the majority of amino acids is weak, the characteristic mass spectra of four amino acids were found in *G*. *elata* extracts.

Peak 3 produced an \[M+H\]^+^ ion at m/z 182.1056 and an \[M-H\]^-^ ion at m/z 180.1078, with fragment ions at m/z 165 \[M+H-NH~3~\] ^+^ and 136 \[M+HCOOH\]^+^. It can be identified as tyrosine based on a previous report \[[@pone.0150647.ref021]\]. Peak 4 showed an \[M+H\] ^+^ at m/z 132.1020 in positive ion mode and was identified as leucine. Product ions at m/z 115 \[M+H-NH~3~\]^+^ and 86 \[M+H-HCOOH\]^+^ were observed in the MS/MS spectrum. The MS data of peak 12 (\[M+H\]^+^ m/z 414.1331 and MS/MS m/z 285/179/233/) indicated that this compound contained m/z 285 \[M+H-147+H~2~O\]^+^, 179 \[M+H-147+H~2~O-106\]^+^ and 233 \[M+H-106-75\]^+^ groups. By comparison with an earlier report \[[@pone.0150647.ref022]\], peak 12 was identified as S-(4-hydroxybenzyl)-glutathione. Peak 14 showed the same behavior in the mass spectrum as peak 12 but with an additional 106 Da fragment, indicating a hydroxybenzyl linkage. MS-MS analysis of precursor ions at m/z 414 \[M+H-106\]^+^, m/z 339 \[M+H-75-106\]^+^, m/z 308 \[M+H-106-106\]^+^, m/z 285 \[M+H-147+H~2~O-106\]^+^, m/z 233 \[M+H-106-75-\]^+^, and m/z 179 \[M+H-147+H~2~O-106-106\]^+^ are characteristic of an amino linkage, and the compound was tentatively identified as *p*-hydroxybenzyl-S-(4-hydroxybenzyl)-glutathione.

### MS^n^ analysis of phenolic in *G*. *elata* {#sec020}

The external standards, parishin, parishin B, and parishin E, were used to study one to third-order collision-induced dissociation (CID) spectra (MS^3^) for phenolic identification. Full confidence fragmentation pathways could be achieved progressively, following comparison of product ion mass spectra of the compounds under investigation with those recorded for parishin ([Fig 2](#pone.0150647.g002){ref-type="fig"}). Analyses of product ion spectra of molecules \[M+Na\]^+^ provided information about the size of substituents as well as substitution patterns of parishin analogues. Similarly, for di- and mono-glycosides of parishin derivatives (9, 13, 22, 26, 29, and 31), MS/MS spectra of the \[M+Na\]^+^ ions contained either \[M+Na-162\]^+^, \[M+Na-106\]^+^, \[M+Na-268\]^+^, \[M+Na-162-268\]^+^, or \[M+Na-106-268\]^+^ (As shown in [S1 Fig](#pone.0150647.s001){ref-type="supplementary-material"}) The six parishin derivatives were tentatively identified as described below.

![MS^n^ spectrum behavior of parishin (A), parishin B (B), parishin E (C) in *G*. *elata*.](pone.0150647.g002){#pone.0150647.g002}

Peak 9 showed an \[M+Na\]^+^ ion at m/z 645.1136, and MS/MS showed consecutive losses of 106 Da at m/z 539 \[M+Na-106\]^+^, 162 Da at m/z 483 \[M+Na-162\]^+^, 268 Da at m/z 377 \[M+Na-268\]^+^, and 430 Da at m/z 215 \[M+Na-268-162\]^+^ from the protonated molecule. The mass spectral behavior and molecular weight were confirmed in negative ion mode, with the deprotonated molecule \[M-H\]^-^ at m/z 621.1660 and MS/MS showing neutral losses of glucoside, H~2~O and CO~2~, at m/z 441 \[M-H-162-H~2~O\]^-^, 459 \[M-H-162\]^-^, 397 \[M-H-162-H~2~O-CO~2~\]^-^, and 369 \[M-H-162-CO~2~\]^-^. The characteristic neutral loss of a 162 Da fragment is typically observed for parishin glucosides and glucoside is also the only substituent previously reported in *G*. *elata* \[[@pone.0150647.ref018]\]. Peak 9 was thus tentatively identified as mono-substituted parishin glucoside.

Peak 13 was tentatively identified as methoxy mono-substituted parishin, based on similar mass spectral behavior to peak 17 (parishin B). Peak 13 had a MW of 490, with a deprotonated molecular ion \[M-H\]^-^ at m/z 489.1247 in negative ion mode. In positive ion mode, a molecular ion was observed at m/z 513.1048 \[M+Na\]^+^ and fragments were observed at m/z 414 \[M+H-106\]^+^ and 215 \[M+Na-268-30\]^+^ during the MS/MS process.

Peak 26 was tentatively identified as methyl parishin, MW 1026, with a deprotonated molecular ion \[M-H\]^-^ at m/z 1025.3138 in negative mode. In positive mode, an ion was observed at m/z 1049.3097 \[M+Na\]^+^, and MS^2^ showed neutral losses of 268 Da and 30 Da as well as characteristic ions at m/z 781 \[M+Na-268\]^+^, m/z 751 \[M+Na-268-30\]^+^, m/z 645 \[M+Na-268-268-162-30\]^+^, and 483 \[M+Na -268-268-30\]^+^, indicating that peak 26 is a methyl-substituted parishin.

The molecular weight of peak 29 was 834, as determined by the ions observed at m/z 833.2500 \[M-H\]^-^ and m/z 857.2483 \[M+Na\]^+^. MS/MS showed neutral loss of 106 (m/z 727 \[M-H-106\]^-^ and m/z 751 \[M+Na-106\]^+^), as well as m/z 589 \[M+Na-268\]^+^, m/z 483 \[M+Na-268-106\]^+^, and m/z 377 \[M+Na-268-106-106\]^+^ in positive mode. In negative mode, m/z 441 \[M-H-268-H~2~O-106\]^-^ and 397 \[M-H-268-106-H~2~O-CO~2~\]^-^ were obtained. These typical fragmentations were observed for peak 29, which was tentatively identified as *p*-hydroxybenzyl di-substituted parishin.

Peak 31 was tentatively identified as *p*-hydroxybenzyl parishin, MW 1102, with a deprotonated molecular ion \[M-H\]---at m/z 1101.3436 in negative mode and \[M+Na\] ^+^ at m/z 1125.3408 in positive mode. Characteristic neutral losses of 106 Da and 268 Da were observed in the MS/MS process. The identification was confirmed by fragments obtained from the ion at m/z 995 \[M-H-106\]^-^, 833 \[M-H-268\]^-^, and 727 \[M-H-268-106\]^-^\_in negative mode, as well as ions at m/z 1019 \[M+Na-106\]^+^, 857 \[M+Na-268\]^+^, 751 \[M+Na-268-268\]^+^, and 483 \[M+Na-268-268-106\]^+^ in positive mode ([Table 5](#pone.0150647.t005){ref-type="table"}).

Based on literature reports \[[@pone.0150647.ref010],[@pone.0150647.ref018],[@pone.0150647.ref020],[@pone.0150647.ref023]--[@pone.0150647.ref026]\], retention times on the C~18~ column, UV-Vis spectra and co-elution with standards, the other peaks were identified as shown in [Table 5](#pone.0150647.t005){ref-type="table"}.

Overall, thirty-one phenolic compounds were identified in fresh *G*. *elata* plant extracts in this study ([Table 5](#pone.0150647.t005){ref-type="table"}). Using UPLC coupled with ESI-triple quadrupole ion MS and ESI-linear ion trap high-resolution MS, mono-substituted parishin glucoside (peak 9), methoxy mono-substituted parishin (peak 13), methyl parishin (peak 26), *p*-hydroxybenzyl di-substituted parishin (peak 29), *p*-hydroxybenzyl parishin (peak 31) were detected and identified for the first time in *G*. *elata*.

Quantitative and qualitative analysis of compounds {#sec021}
--------------------------------------------------

Significant qualitative differences were found in the metabolites detected in different species as well as in plants collected from different producing areas. Interestingly, the characteristic compound, gastrodin, was not detected in the red *G*. *elata* cultivar collected from Shanxi province. S-(4-hydroxybenzyl)-glutathione was detected only in the hybrid obtained from Sichuan province.

Compounds gastrodin, parishin E, parishin B, parishin were quantified using their available counterparts as standards, and the other parishin derivative compounds using parishin as the standard, while other compounds using gastrin as the standard. all the studied 31 compounds were classified as five groups include amino acids, nucleosides, S-(4-hydroxybenzyl)-glutathione, gastrodin, parishin derivates for further statistical analysis.

Principal component analyses {#sec022}
----------------------------

Principal component analysis (PCA) was used to provide an overview of the complete data set, showing variability between compounds detected and *G*. *elata* growth area or species. PCA using these attributes could explain 79.49% of the variance, partitioned as 43.64% in principal component 1 (PC 1) and 35.85% in principal component 2 (PC 2) ([Fig 3](#pone.0150647.g003){ref-type="fig"}). The loading of PC 1 showed strong positive correlations with S-(4-hydroxybenzyl)-glutathione, gastrodin, and parishin derivatives whereas PC 2 showed an important positive correlation with amino acids and nucleosides. Relationships between *G*. *elata* collection areas and detected compounds are shown in [Fig 3A](#pone.0150647.g003){ref-type="fig"} and [Fig 3B](#pone.0150647.g003){ref-type="fig"} and relationships between *G*. *elata* species and detected compounds are shown in [Fig 3A and 3C](#pone.0150647.g003){ref-type="fig"}.

![Positions of PCA scores (PC1, PC2) of eight *G*. *elata* cultivars, based on amino acids, nucleosides, S-(4-hydroxybenzyl)-glutathione, gastrodin, parishin derivatives compound content.\
The four compounds (gastrodin, parishin E, parishin B, parishin) were quantified by comparison with external standards, while the other parishin derivatives were quantified by comparison with an equivalent of parishin, and the other compounds were compared with an equivalent of gastrodin. Percentages in parentheses represent principal component variance. Numbers in figure B and C correspond to cultivar number in [Table 1](#pone.0150647.t001){ref-type="table"}. (A) Sore scatter plot; (B) loading plot based on different area;(C)loading plot based on different cultivars. All the quantitative data was acquired by UPLC-ESI-triple quadrupole ion MS.](pone.0150647.g003){#pone.0150647.g003}

As shown in [Fig 3B](#pone.0150647.g003){ref-type="fig"}, the eight *G*. *elata* cultivars could be divided into four groups. Group I, comprising two *G*. *elata* cultivars (4 and 6) collected from Sichuan province, was located to the right of the PC1 axis and above the PC2 axis. *G*. *elata* cultivars collected from Sichuan province were characterized by high levels of amino acids and nucleosides. Group II consisted of one cultivar (5) from Sichuan province and was characterized by high levels of S-(4-hydroxybenzyl)-glutathione and gastrodin. Group III was located in the second quadrant and contained cultivars 2 (Guizhou, *G*. *elata*) and 7 (Shanxi, *G*. *elata*,) which have relatively high levels of amino acids. Group IV, located in the lower left part of the scatter plot, included two *G*. *elata* samples obtained from Guizhou (1 and 3) and one *G*. *elata* sample obtained from Yunnan (8) and was characterized by very low individual compound content.

PCA demonstrated a lack of strong characteristic clustering among different *G*. *elata* species. To some extent, our results show that geographic insulation affects metabolite synthesis to a greater extent than species diversity.

Conclusions {#sec023}
===========

A reliable and effective method using UPLC coupled with ESI-triple quadrupole ion MS and ESI-linear ion trap high-resolution MS was successfully developed for online identification of low molecular weight metabolites of *G*. *elata*. A total of 31 compounds were identified or tentatively characterized, based mainly on fragment ion information obtained by UPLC-MS/MS. Five of these compounds were identified for the first time. PCA showed that the synthesis of *G*. *elata* metabolites varies with both species and geographic insulation. The analysis study of the active compounds in *G*. *elata* where quality control is of interest, in which case identification based on metabolites detection is possible and necessary.

Supporting Information {#sec024}
======================

###### MS/MS spectra of peak 9, peak 13, peak 26, peak 31.

(JPG)
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Click here for additional data file.
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